About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

3D Printed Custom Applicators for HDR BT (DISCO) | Clinical Trials | Clareo Health

RECRUITINGNA

3D Printed Custom Applicators for HDR BT (DISCO)

Study of 3D-printed Custom Applicators for Intracavitary HDR Gynaecological Brachytherapy (DISCO)

NCT06432478•Royal North Shore Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Gynecologic CancerEndometrial CancerVaginal Cancer+1 more

Interventions

3D-printed custom applicator

Locations

1

Australia

Locations (1)

Royal North Shore Hospital

St Leonards, New South Wales, Australia

Key Dates

Start Date

November 24, 2023

Primary Completion Date

September 1, 2028

Completion Date

September 1, 2028

Last Updated

February 6, 2026

Related Studies

RECRUITINGPhase 3

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

NCT06340568

Endometrial Cancer

RECRUITINGPhase 3

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

NCT06952504

Endometrial Cancer

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Breast CancerSmall Cell Lung Cancer+10 more

RECRUITINGPhase 1/2

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

NCT06253494

Endometrial CancerCancer of Endometrium+2 more

RECRUITINGPhase 1

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Advanced Ovarian CancerPlatinum-resistant Ovarian Cancer+4 more

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

NCT05990426

Ovary CancerEndometrial Cancer+1 more

View all related studies

Contacts

Marita Morgia, MD

CONTACT

9463 1300 Marita.Morgia@health.nsw.gov.au

Jeremy Booth, PhD QMP

CONTACT

94631300 jeremy.booth@health.nsw.gov.au

Sponsors

Lead Sponsor

Royal North Shore Hospital

Collaborators

Northern Sydney and Central Coast Area Health Service

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 6, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions